# Orchid Pharma Ltd (ORCHPHARMA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹707.55
Day Change: -1.08%
52W High: ₹899
52W Low: ₹480
Market Cap: ₹3,617 Cr

## Valuation
P/E: 188.64
P/B: 2.85
EPS: ₹3.78
Book Value: ₹249.86
Dividend Yield: 0%

## Returns
1Y Return: -11.54%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: -1.5%
Profit Growth: 0%
EBITDA Margin: 1.92%
Operating Margin: -12.26%

## About
Orchid Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Orchid Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Intimation Under Regulation 30
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:04.699Z
Price History Updated: 2026-05-18T22:58:44.691Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:44.691Z
Quant Updated: 2026-05-18T22:58:44.691Z
Sentiment Updated: 2026-05-18T22:58:44.691Z
Financials Status: current
Financials Updated: 2026-05-18T14:30:47.233Z
Financials Last Attempt: 2026-05-18T14:30:47.233Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015
            
            
              18m)
Revenue: ₹1948 Cr
Operating Profit: ₹110 Cr (OPM 6%)
Net Profit: ₹-560 Cr
Tax: ₹-573 Cr

## Annual P&L History
Mar 2015
            
            
              18m: Rev ₹1948Cr | PAT ₹-560Cr | OPM 6%
Mar 2016: Rev ₹1747Cr | PAT ₹-197Cr | OPM 18%
Mar 2017: Rev ₹873Cr | PAT ₹-279Cr | OPM 20%

## Balance Sheet (Mar 2015)
Total Assets: ₹4651 Cr
Total Liabilities: ₹4651 Cr
Borrowings: ₹3204 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Manish  Dhanuka, MD & Director
- Sunil Kumar Gupta, Chief Financial Officer
- Kapil  Dayya, Company Secretary & Compliance Officer
- Mridul  Dhanuka, Whole Time Director
- A.  Chandrasekar, Vice President of Operations

---
Source: rupiya.io/stocks/orchpharma
Disclaimer: For research and education only. Not investment advice.